Time-Restricted Eating for Coronary Heart Disease
(TREat-CR Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores whether time-restricted eating (TRE) can enhance the benefits of cardiac rehabilitation for individuals with heart disease. TRE involves consuming all meals within an 8-hour window, followed by 16 hours of fasting each day, which may improve heart health when combined with exercise. Participants will either follow standard cardiac rehabilitation—a structured program of exercise and education—or add TRE to assess its impact on their recovery. Individuals with coronary artery disease or peripheral vascular disease who are open to random assignments may be suitable candidates. As an unphased trial, this study provides a unique opportunity to investigate innovative lifestyle changes that could improve heart health.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.
What prior data suggests that time-restricted eating is safe for individuals with coronary heart disease?
Research shows that time-restricted eating (TRE) might be a safe and effective way to improve heart health. Studies suggest that TRE can lower some risk factors for heart disease. For example, some research found that people who practice fasting, a type of TRE, may have better heart health and a lower chance of heart problems.
However, one study found a higher risk of heart issues when eating was limited to a very short time. This indicates that while TRE can be helpful, the specific timing and length of the eating period are important for safety.
Overall, TRE is generally well-tolerated, but results can vary from person to person. Consulting healthcare professionals is advisable to determine if this approach is suitable.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores a new approach to managing coronary heart disease by combining time-restricted eating (TRE) with standard cardiac rehabilitation. Unlike traditional treatments that focus solely on medication and exercise, this method emphasizes meal timing, encouraging participants to eat only between 11 am and 7 pm. This strategy may help improve metabolism and enhance the body's natural circadian rhythms, potentially offering additional benefits in managing heart disease. The approach is unique because it integrates dietary timing with physical activity, possibly leading to better cardiovascular outcomes.
What evidence suggests that time-restricted eating could be an effective addition to cardiac rehabilitation for coronary heart disease?
Research has shown that time-restricted eating (TRE), a type of intermittent fasting, can benefit heart health. TRE has been linked to improved blood fat levels, weight loss, and better insulin use, all of which support heart health. Some studies suggest TRE might lower risks related to heart disease, making it a promising option for prevention. However, results are mixed, as other studies have shown increased heart risks with TRE. Despite these concerns, many people have experienced better heart function with fasting practices like Ramadan. In this trial, one group of participants will receive standard cardiac rehabilitation, while another group will receive the same program with the addition of TRE. Overall, TRE could be a helpful part of heart health programs, but results can vary for each person.12367
Who Is on the Research Team?
Paul Oh, MD
Principal Investigator
University Health Network, Toronto
Amy Kirkham, PhD
Principal Investigator
University of Toronto, KITE Research Institute
Are You a Good Fit for This Trial?
This trial is for men and women eligible for outpatient cardiac rehabilitation due to coronary artery disease, who are willing to follow the study's procedures. It excludes those with communication barriers, night shift workers, recent mothers or pregnant women, individuals with eating disorders or very low body weight, people who eat less than 3 meals a day or have an eating window under 12 hours, and diabetics on insulin.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a 16-week cardiac rehabilitation program with or without time-restricted eating (TRE). The TRE group restricts eating to an 8-hour window daily.
Follow-up
Participants are monitored for safety and effectiveness after treatment, including adherence to TRE and cardiac rehabilitation outcomes.
Long-term Follow-up
Participants are monitored for adverse events such as re-hospitalizations and recurrent cardiac events.
What Are the Treatments Tested in This Trial?
Interventions
- Standard cardiac rehabilitation
- Time-Restricted Eating
Standard cardiac rehabilitation is already approved in United States, European Union, Canada for the following indications:
- Secondary prevention of cardiovascular disease
- Improvement of cardiometabolic health parameters
- Cardiovascular disease management
- Rehabilitation post-myocardial infarction
- Heart disease management
- Improvement of cardiovascular risk factors
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Toronto
Lead Sponsor
University Health Network, Toronto
Collaborator